Journal of Global Antimicrobial Resistance

Elsevier

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Journal of Global Antimicrobial Resistance is an open-access journal published by Elsevier in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE according to the sources read. Declared publication charge: 1,890 USD. Declared review time at DOAJ: 22 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
2213-7165 · 2213-7173
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
1,890 USD
Articles in DOAJ
2135
Declared review time
22 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2021-03-12
  • MEDLINE · 2016-01-01
Indexing
DOAJ · MEDLINE
APC
1,890 USD
Declared review time (DOAJ)
22 weeks
Actual review time (measured)
130 days received→accepted — computed from PubMed (n=100)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

2135

Most recent article

last month

Average review time (journal-declared via DOAJ)

22weeks

Works in OpenAlex

3232

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

72

i10-index

1382

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2026-04-27
Added to DOAJ
2021-03-12
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
71%
ORCID iDs in current deposits
61%
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101622459
Classification2

Subjects (DOAJ)

Science: Microbiology

LCC codes

QR1-502

Subject areas

  • Antibiotic Resistance in Bacteria
  • Antibiotic Resistance in Bacteria
  • Antibiotic Use and Resistance
  • Antibiotic Use and Resistance
  • Antimicrobial Resistance in Staphylococcus
  • Antimicrobial Resistance in Staphylococcus
  • Bacterial Identification and Susceptibility Testing
  • Antibiotics Pharmacokinetics and Efficacy
Show all subjects (50)
  • Antibiotics Pharmacokinetics and Efficacy
  • Bacterial Identification and Susceptibility Testing
  • Infections and bacterial resistance
  • Infections and bacterial resistance
  • Bacterial biofilms and quorum sensing
  • Bacterial biofilms and quorum sensing
  • Pharmaceutical and Antibiotic Environmental Impacts
  • Pharmaceutical and Antibiotic Environmental Impacts
  • Nosocomial Infections in ICU
  • Nosocomial Infections in ICU
  • Escherichia coli research studies
  • Escherichia coli research studies
  • Tuberculosis Research and Epidemiology
  • Tuberculosis Research and Epidemiology
  • Salmonella and Campylobacter epidemiology
  • Salmonella and Campylobacter epidemiology
  • Pneumonia and Respiratory Infections
  • Pneumonia and Respiratory Infections
  • Mycobacterium research and diagnosis
  • Vibrio bacteria research studies
  • Mycobacterium research and diagnosis
  • Vibrio bacteria research studies
  • Urinary Tract Infections Management
  • Urinary Tract Infections Management
  • Enterobacteriaceae and Cronobacter Research
  • Enterobacteriaceae and Cronobacter Research
  • Bacterial Genetics and Biotechnology
  • Bacterial Genetics and Biotechnology
  • Clostridium difficile and Clostridium perfringens research
  • Clostridium difficile and Clostridium perfringens research
  • Streptococcal Infections and Treatments
  • Streptococcal Infections and Treatments
  • Antifungal resistance and susceptibility
  • Antifungal resistance and susceptibility
  • Genomics and Phylogenetic Studies
  • Genomics and Phylogenetic Studies
  • Educational Robotics and Engineering
  • Educational Robotics and Engineering
  • Bacteriophages and microbial interactions
  • Bacteriophages and microbial interactions
  • Antimicrobial agents and applications
  • Diverse Scientific and Economic Studies

Keywords (DOAJ)

  • antimicrobial resistance
  • infectious diseases
  • clinical microbiology
  • animal infection control
  • public health
  • antibiotic resistance

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: